<?xml version="1.0" encoding="UTF-8"?>
<p>Different case reports have described the use of MQ by itself in HIV-positive PML patients, sometimes with repression of JCPyV replication [
 <xref rid="B122-microorganisms-08-00085" ref-type="bibr">122</xref>,
 <xref rid="B123-microorganisms-08-00085" ref-type="bibr">123</xref>,
 <xref rid="B124-microorganisms-08-00085" ref-type="bibr">124</xref>,
 <xref rid="B125-microorganisms-08-00085" ref-type="bibr">125</xref>] and rarely with the death of the patient [
 <xref rid="B126-microorganisms-08-00085" ref-type="bibr">126</xref>]. The combined treatment MQ and mirtazapine was administered to HIV-positive patients, leading to a failure because of premature death and not always due to the PML itself [
 <xref rid="B127-microorganisms-08-00085" ref-type="bibr">127</xref>,
 <xref rid="B128-microorganisms-08-00085" ref-type="bibr">128</xref>].
</p>
